We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
GlaxoSmithKline said Monday that chairman Philip Hampton plans to step down from his position and the process to find a successor has been initiated. Hampton joined the drugmaker's board at the start of 2015, becoming chairman later that year.